Home | Links | Contact Us | More About Intellectual Property | Bookmark
Search patents:
Home Gene Therapy Process-for-the-synthesis-of-oligomeric-compounds

 Radiolabeled fusion toxins for cancer therapy
The present invention describes the synthesis and purification of a new class of compounds known as ...


 Genetically modified cells expressing a TGF.beta. inhibitor, the cells being lung cancer cells
OF THE PREFERRED EMBODIMENT Lung cancers account for 30% of all death due to cancer in the United S...


 Auto-ligating oligonucleotide compounds
OF THE INVENTION The invention relates to a method and compositions for in situ formation of an ...


 Nucleic acids encoding transcription factor APRF (acute phase response factor)
What is claimed: 1. An isolated DNA molecule which encodes a human APRF polypeptide having the ...


 Antisense modulation of stat3 expression
OF THE INVENTION STAT3 plays an important role in cytokine signal transduction. Overexpression and/...


 Cold-active beta-galactosidase, the process for its preparation and the use thereof
The object of the present invention is to hydrolyse lactose by using a .beta.-galactosidase, which ...


 Method of delivering powder transdermally with needless injector
What we claim is: 1. A method of therapeutic treatment, comprising transdermally delivering ...


 Telomere repeat binding factors and diagnostic and therapeutic use thereof
The present invention provides vertebrate telomeric binding factors (TRFs) that bind to the TTAGGG ...


 Protease-activated receptor PAR4 (ZCHEMR2)
What is claimed is: 1. An isolated polynucleotide molecule that encodes a polypeptide comprising ...


 Systemic drug delivery compositions comprising a polycationi substance
I claim: 1. A method of systemically delivering a pharmaceutically effective amount of a ...


 Process for the synthesis of oligomeric compounds

Details
Inventors: Capaldi, Daniel C.; Ravikumar, Vasulinga T.;
Assignee: Isis Pharmeuticals, Inc. (Carlsbad, CA)
Primary Examiner: Crane; L. Eric
Assistant Examiner:
Attorney, Agent or Firm: Woodcock Washburn Kurtz Mackiewicz & Norris LLP

Synthetic processes are provided wherein oligomeric compounds are prepared having phosphodiester, phosphorothioate, and phosphorodithioate covalent linkages. Also provided are synthetic intermediates useful in such processes.

DETAILED DESCRIPTION What is claimed is: 1.
A method for the preparation of an oligomeric compound having a moiety of Formula I: ##STR38## wherein: X.
sub.
4 is Z or H; Z is CN, halogen, alkaryl, substituted sulfoxyl, substituted sulfonyl, or a substituted thio group, wherein said substituent is alkyl, aryl, or alkaryl; and X.
sub.
1 is O or S; comprising the steps of: (a) providing a compound having the Formula II: ##STR39## wherein: each R.
sub.
1, is, independently, H, --OH, --F, or --O--X.
sub.
3 --D; X.
sub.
3 is alkylenyl having from 1 to 10 carbons; D is H, amino, protected amino, alkyl substituted amino, imidazolyl, or (--O--X.
sub.
3).
sub.
p H where p is 1 to about 10; each X.
sub.
2 is O or S; R.
sub.
3 is selected from the group consisting of hydrogen, a hydroxyl protecting group, and a linker connected to a solid support; each B, independently, is selected from the group consisting of a naturally occurring nucleobase, a non-naturally occurring nucleobase, a protected naturally occurring nucleobase, and a protected non-naturally occurring nucleobase; n is 0 to about 50; each Q is --X.
sub.
1 H or ##STR40## R.
sub.
5 is selected from the group consisting of --N(R.
sub.
6).
sub.
2, a heterocycloalkyl ring containing from 4 to 7 atoms, and having up to 3 heteroatoms selected from nitrogen, sulfur, and oxygen, and a heterocycloalkenyl ring containing from 4 to 7 atoms, and having up to 3 heteroatoms selected from nitrogen, sulfur, and oxygen; and R.
sub.
6 is straight or branched chain alkyl having from 1 to 10 carbons; and (b) reacting the compound of Formula II with a compound having Formula III: ##STR41## wherein R.
sub.
3a is hydrogen; and R.
sub.
2 is a hydroxyl protecting group, or a linker connected to a solid support, provided that R.
sub.
2 and R.
sub.
3 are not both simultaneously a linker connected to a solid support; to form the oligomeric compound.
2.
The method of claim 1 further comprising the step of oxidizing or sulfurizing the oligomeric compound to form a further compound having Formula III, wherein R



Related patents
  Process for oligonucleotide synthesis
OF THE PREFERRED EMBODIMENTS The present invention is directed to methods for linking a phosphoramidite nucleoside to a solid support-bound nucleoside. These methods ...
  Derivatized oligonucleotides having improved uptake and other properties
OF THE INVENTION Antisense therapeutics can be practiced in a variety of organisms ranging from unicellular prokaryotic and eukaryotic organisms to multicellular ...
  Process for the synthesis of oligomeric compounds
What is claimed is: 1. A compound having the formula: ##STR38## wherein: X.sub.4 is Z or H; Z is CN, a halogen radical, , alkaryl, substituted sulfoxyl, substituted ...
  Processes for the synthesis of oligomeric compounds
OF PREFERRED EMBODIMENTS The present invention provides methods for the preparation of oligomeric compounds having at least one phosphodiester or phosphorothioate ...
  Methods of synthesis and use of radiolabelled platinum chemotherapeutic agents
OF THE INVENTION Usually, in the method of synthesis of the radiolabelled platinum chemotherapeutic agent the step of converting the metal halide into a radiolabelled ...
  Pharmaceutical composition for diabetic neuropathy
What is claimed is: 1. A method for the prophylaxis of diabetic peripheral neuropathy, which comprises administering an effective amount of cytidine 5'-diphosphocholine ...
  Rapid single-cycle assay for human immunodeficiency virus type-1 drug resistance
This invention aids in fulfilling this need in the art by providing an in vitro, single cycle, recombinant virus assay (RVA) for determining inhibition of HIV ...
  Compositions and methods for sensitive detection of HIV infection and monitoring of drug resistance
OF THE INVENTION The present invention relates to new and useful methods including methods for detecting HIV, methods for detecting HIV drug resistance, methods for ...
  Continuous process for ethanol production by bacterial fermentation
The accompanying FIGURE will provide a background for the following discussion in which the method and apparatus for carrying out this invention are described in detail....
  Stable solution of hyaluronate in a balanced salt medium
What is claimed is: 1. A physiological visco-elastic formulation consisting of sodium hyaluronate in an amount in the range of about 0.1% to about 5% by weight in a ...

0.004

Archive: All patents - Links

Copyright (c)2006 Eipa-patents.org - All rights reserved